Alternative forms of assessment are beginning to reach higher education classrooms, including ones at here Hiram. Hailee ...

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced the US ...

MMJ.com is proud to announce the launch of our monthly Veteran Appreciation Giveaway, offering 25 U.S. military veterans a free medical marijuana evaluation each month. This campaign highlights ...

Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...

Expands footprint in DJ Basin to ~55,000 net acres and inventory life to ~10 yearsIncreases average daily production by ~25,700 net BOEPD ...

Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement ...

Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to ...

Olverembatinib (HQP1351), a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI, has been approved in ...

Detailed price information for Americas Silver Corp (USA-T) from The Globe and Mail including charting and trades.

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the confirmatory Phase 3 RESTORE-ALS tr ...

Angiosarcoma is a rare and aggressive malignant neoplasm that arises from endothelial cells of blood or lymphatic vessels, ...